Evaluate the Safety, Tolerability, PK, and PD of JMT206 Injection in Healthy Participants

NCT07419698 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

44

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Participants

Interventions

BIOLOGICAL: JMT206
DRUG: Placebo

Sponsor

Shanghai JMT-Bio Inc.